Olympia Compounding Pharmacy dba Olympia Pharmacy recalls NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML cont…

Recall date

March 8, 2022

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0719-2022

FDA classification

Class II

Brand / firm

Olympia Compounding Pharmacy dba Olympia Pharmacy

Sold / distributed

Nationwide in the USA including Puerto Rico.

Why it was recalled

Product found to be Sub Potent or Exceeded reconstitution time

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00